(주)바이오스마트
| KRW bn | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 116.5 | 112.3 | 120.8 | 125.5 | 124.2 | 145.3 | 167.6 | 170.9 |
| Operating income | 7.2 | 5.6 | 4.2 | 7.6 | 5.1 | 10.1 | 5.1 | 8.3 |
| Net income | 2.4 | 2.8 | -2.8 | 4.9 | 4.0 | 7.2 | 2.2 | 5.7 |
| Cash from operations | 10.2 | -0.5 | 6.6 | 7.6 | 10.3 | -9.8 | 11.9 | 6.8 |
| Free cash flow | 8.6 | -1.4 | 5.0 | 6.6 | -19.4 | -14.6 | 5.2 | 2.5 |
| KRW bn | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 456.2 | 484.3 | 482.8 |
| Operating income | 10.1 | 20.2 | 22.6 |
| Net income | 16.2 | 1.1 | 9.0 |
| Cash from operations | 1.2 | 3.7 | 24.1 |
| Free cash flow | -1.9 | -3.2 | -9.2 |
| Gross margin | 14.3% |
| ROA | 6.0% |
| Liabilities / equity | 0.66x |
| Current ratio | 1.43x |
| FCF margin | -4.3% |
| CFO / net income | 1.01x |
| Net debt (KRW) | 50.6 bn |
| Filing | Form | ||
|---|---|---|---|
| Mon 16 Nov 2026 | |||
| Quarterly Report — 2026.09 | 10-Q | ||